Related Experiment Videos
T-cell clones specific for synthetic polypeptides in cellular collaborations
1Department of Chemical Immunology, Weizmann Institute of Science, Rehovot, Israel.
Advances in Experimental Medicine and Biology
|January 1, 1987
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Curcumin synergistically potentiates the growth inhibitory and pro-apoptotic effects of celecoxib in pancreatic adenocarcinoma cells.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2006
Autoantibodies to a NR2A peptide of the glutamate/NMDA receptor in sera of patients with systemic lupus erythematosus.
Annals of the rheumatic diseases·2005
Nucleoskeletal Proteins in Early Embryogenesis.
Advances in experimental medicine and biology·2026
Nuclear Dynamics and Its Timing Regulation Revealed by Live-Cell Imaging.
Advances in experimental medicine and biology·2026
Histone Modifications in Mammalian Early Embryos.
Advances in experimental medicine and biology·2026
Oocyte Kinetochores at the Nexus of Meiotic Drive and Segregation Fidelity.
Advances in experimental medicine and biology·2026
Asymmetric Chromosome Establishment and Segregation During Germline Stem Cell Division.
Advances in experimental medicine and biology·2026
Non-random Sister Chromatid Segregation Mediated by Ribosomal DNA in Drosophila Male Germline Stem Cells.
Advances in experimental medicine and biology·2026
Development of a Novel, Eco-Friendly Mechanical Cell Lysis Process Using Hollow Fiber Filter for AAV Manufacturing.
Biotechnology and bioengineering·2026
Programmed repair of disease-causing UGA premature termination codons in mammalian brain.
Nucleic acids research·2026
Molecular profiling and functional analyses of umbilical cord mesenchymal stem cell-derived extracellular vesicles for dry eye diseases.
Extracellular vesicles and circulating nucleic acids·2026
Immunotherapy for tuberculosis: current landscape, mechanistic insights, and translational perspectives.
Frontiers in immunology·2026
Real-World Effectiveness and Safety of Tildrakizumab in Patients With Moderate-to-Severe Psoriasis After Failure of Ustekinumab: A Multicenter Retrospective Study.
The Journal of clinical and aesthetic dermatology·2026